Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma

Citation
Sa. Abdulkadir et al., Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma, HUMAN PATH, 32(9), 2001, pp. 935-939
Citations number
17
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
HUMAN PATHOLOGY
ISSN journal
00468177 → ACNP
Volume
32
Issue
9
Year of publication
2001
Pages
935 - 939
Database
ISI
SICI code
0046-8177(200109)32:9<935:FAELOT>2.0.ZU;2-F
Abstract
The transcription factor EGR1 is frequently overexpressed in human prostate cancer and regulates the expression of several genes important for tumor p rogression. In addition, mice lacking the Egr1 gene show a defect in prosta te tumorigenesis. NAB2 is a novel corepressor molecule that modulates EGR1 activity and is induced by the same stimuli that induce EGR1. The human NAB 2 gene has been localized to 12q13.3-14.1, within a chromosomal region that is thought to harbor a prostate tumor suppressor. We have examined the exp ression of NAB2 in human prostate carcinoma specimens. We show here that NA B2 protein expression is lost in a majority of primary prostate carcinoma s pecimens, including many samples that have high EGR1 levels. This loss occu rs early in the tumorigenic process and is sustained, as it is seen in prec ursor prostatic intraepithelial neoplasia lesions as well as in metastases. Furthermore, loss of NAB2 did not correlate with the tumor grade or stage. Our findings suggest that high levels of EGR1 coupled with low levels of N AB2 can result in high, unrestrained EGR1 transcriptional activity in human prostate cancers. Copyright (C) 2001 by W.B. Saunders Company